LEEF Brands CEO Outlines Cultivation Plan for Interstate, Global Sales

What Anderson Put on the Record

Anderson's interview covers three topics: cultivation economics, lessons from New York, and readiness for commerce across state and national lines.

Cannabis Industry Journal published the feature on Oct. 16, 2026, in its cultivation coverage. The published summary names those three threads and little else.

That limits what can be reported as fact. We haven't seen the full interview text, so this story doesn't attribute figures, quotes or specific operating details to Anderson beyond what the summary states.

Cultivation Economics Are the Foundation

A company preparing for new markets has to prove it can grow at a cost that survives price compression.

The cleanest read on Anderson's framing is that cultivation comes first. Brands, licenses and distribution deals only matter if the cost per pound holds up.

Operators won't find that controversial. It's a notable view, though, for a company that carries a brand name, because it signals the grow is treated as the core asset rather than a supply line for marketing.

New York as a Stress Test

Anderson cited New York as a source of lessons, though the summary doesn't say what those lessons were.

New York's adult-use market is overseen by the state's Office of Cannabis Management (OCM). Operators there have worked through licensing sequencing, local rules and a market that has taken shape unevenly.

Which of those pressures shaped LEEF's thinking is unclear. Anyone writing a confident takeaway from a summary line is guessing. We won't.

Interstate Commerce Is an Option, Not a Market

Federal law still bars cannabis from crossing state lines, so any interstate plan is a bet on a legal change that hasn't happened.

Under the Controlled Substances Act, moving cannabis between states remains illegal even where both states license it, so companies preparing for that day are effectively paying for optionality.

The cost is real. Capital spent on scale, compliance systems and product consistency earns nothing until the law shifts, and operators also still carry the tax burden of 280E, which bars standard business deductions for businesses trafficking in Schedule I or II substances. Waiting is expensive.

Still, building ahead is a defensible call. In a market defined by license-bound silos, the operators with consistent, scalable product are the ones best placed when a door opens. That math is hard to argue with.

The International Angle

International commerce adds a second legal gate: the importing country's rules, plus U.S. federal permission to export.

Some countries, Germany among them, import medical cannabis under their own regulatory frameworks. Supplying them means meeting standards on quality, documentation and traceability that go well beyond a state compliance program.

Anderson's decision to put international commerce alongside interstate commerce suggests LEEF sees product standards as the common denominator. A facility built to a high, repeatable standard can, in theory, serve either route. That's an inference from the framing, not a statement from the company.

What Operators and Investors Should Take From It

The practical lesson is to treat cultivation cost and consistency as the assets that carry over into any future market.

Three questions follow for anyone evaluating a company with this posture:

• What is its all-in cost per pound, and how has it moved?
• How much capital is committed to markets that may not open soon?
• Which of its licenses, such as New York or California, could plausibly connect to an interstate pathway?

Management talk about readiness isn't evidence of readiness. The numbers are.

What We Don't Know Yet

The public summary leaves out the figures, facility details and timelines that would let outsiders test Anderson's strategy.

There's no stated production capacity, no cost data and no timeline for interstate or export activity. Those gaps matter more than the framing does.

For full background on the company, see the CannIntel topic hub on LEEF Brands. We'll update it if the full interview or company filings supply the missing detail.

The next signal to watch: any LEEF disclosure of cultivation cost or capacity, and whether Congress or the DEA moves on interstate rules that would turn this positioning from a bet into a business line.